BCM
IDXX icon

Blume Capital Management’s Idexx Laboratories IDXX Stock Holding History

Blume Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100
Closed -$24K – 226
2020
Q1 		$24K Hold
100
– – 0.02% 139
2019
Q4 		$26K Sell
100
-100
-50% -$26.4K 0.01% 148
2019
Q3 		$54K Buy
+200
New +$55.7K 0.03% 125

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Blume Capital Management's IDXX Position: Q2 2020 in Review

Blume Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2020, closing a stake of 100 shares — an estimated $24K sold.

Blume Capital Management first reported a position in IDXX in Q3 2019 and held it in 3 quarters. The position peaked at $54K in Q3 2019. 802 funds tracked by Wall St. Rank hold IDXX as of Q2 2020.

  • Blume Capital Management reported no remaining Idexx Laboratories position as of Q2 2020 after selling out during the quarter.
  • Blume Capital Management sold 100 Idexx Laboratories shares in Q2 2020, an estimated $24K.
  • Blume Capital Management first reported a position in Idexx Laboratories in Q3 2019 and held it in 3 quarters.
  • Blume Capital Management's Idexx Laboratories position peaked at $54K in Q3 2019.
  • 802 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2020.

Based on Blume Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.